
Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

